An important use of psilocybin or magic mushrooms
Results of the recent research by Johns Hopkins University experts, however, uncovered an important use of the substance.
“One week after the treatment was completed, about 67-percent of people had a clinically significant response,” Davis said, “and 58-percent of people were in complete remission from depression.”
These results, according to the study, are four times more effective than any antidepressant drug available today.
Psilocin, which is present in most psychedelic mushrooms together with its phosphorylated counterpart psilocybin, work by activating certain neurotransmitters in the brain, such as 5-HT2A, 5-HT2B, and 5-HT2C.
Alan Kozikowski, an American medicinal chemist, and drug designer told Observer that psilocybin-like drug targeting specific receptors in just the right amount could be an “effective treatment for opiate addiction as well as eating disorders—two conditions that the COVID-19 pandemic and subsequent economic havoc and social-distancing isolation can trigger—and treatment-resistant epilepsy.”
Just recently, the Canadian government has allowed people in the country with a terminal illness to possess and consume psilocybin or magic mushrooms and later granted 16 healthcare experts the same exemptions.
—————————————-
